 Home > Chemicals Industry > China Chemical > The development and listing of innovative drugs is in good shape. How can companies do well as "engines"?

The development and listing of innovative drugs is in good shape. How can companies do well as "engines"?

 Last Update: 2022-02-22
 Source: Internet
 Author: User

Tags

flooring products

chemical hazard diamond

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[ Market Analysis of Chemical Machinery Equipment Network ] In recent years, driven by favorable policies and market environment, the development and listing of domestic innovative drugs has been very good
.
The pharmaceutical equipment is an indispensable tool and equipment in the pharmaceutical production process, and is called the "engine" of the pharmaceutical industry
.
Under the new situation, how should the pharmaceutical machinery industry do its job well?

Chemical Machinery Equipment Network Market Analysis Chemical Machinery Equipment Pharmaceutical Equipment

The domestic innovative drug R&D and listing situation is very good

In recent years, with the continuous development of the domestic pharmaceutical industry, the acceleration of new drug review and approval, and China's entry into the international organization ICH, local innovative companies have continued to rise, and the entire industry has entered a high-speed growth channel
.
Since 2020, China's pharmaceutical industry has received further attention and has ushered in more development opportunities.
The industry prospects are generally optimistic in the industry
.

　　From the perspective of the speed of medical review and approval, in 2020, the Center for Drug Evaluation (CDE) of the State Food and Drug Administration completed a total of 11,582 registration applications for traditional Chinese medicines, chemical drugs, and biological products, an increase of 32.
67% over the previous year
.
Among them, 8,606 registration applications requiring technical review were completed, an increase of 26.
24% over the previous year; 2,972 registration applications were completed with direct administrative approval
.
In addition, 94.
48% of the registration applications for traditional Chinese medicines, chemical medicines and biological products were reviewed and approved by the Center for Drug Evaluation within the time limit, a record high
.

　　In addition, judging from the speed at which new drugs are approved for marketing, in the first half of 2021 alone, the National Medical Products Administration (NMPA) has approved the launch of a number of innovative products, including CAR-T cell therapy products, akirenxe injection, pamiparin Li Capsules, Vidicitumumab for Injection, Donafenib Tosylate Tablets,
etc.
The data shows that as of June 28, 2021, a total of 21 domestically produced Class 1 new drugs have been approved for marketing, doubling the number of approvals compared with the same period last year
.

　　With the aging of the population, the increase in the number of patients with chronic diseases, and the upgrading of residents' consumption levels, the demand for drugs, including innovative drugs, will continue to expand
.
In addition, with the promotion of policies such as the normalization of centralized procurement and the consistency evaluation of generic drugs, China is also accelerating the opening of the road of pharmaceutical innovation.
The domestic innovative R&D and listing situation is very good, and local innovative drug companies are showing a thriving trend
.
The industry predicts that in the next 3 to 5 years, more and more Chinese pharmaceutical companies will attract international attention and have the opportunity to enter the international stage
.

　　How should the pharmaceutical machinery industry do the "engine" work?

　　Pharmaceutical equipment is an indispensable tool in the pharmaceutical production process and is called the "engine" of the pharmaceutical industry
.
Under the new situation, how should the pharmaceutical machinery industry do its job well?

　　First, equipment innovation and product line upgrades are imperative
.
In the process of accelerating pharmaceutical innovation, pharmaceutical companies' demand for pharmaceutical equipment, especially high-end pharmaceutical equipment will continue to expand.
Therefore, pharmaceutical machine companies should seize the new needs and requirements of users, continue to innovate and improve equipment, and create more intelligent, A pharmaceutical machine product with improved quality, enhanced efficiency and high stability
.

　　Second, increase investment in research and development to increase the added value of products
.
The field of high-end pharmaceutical machines in China has been monopolized by imported products for a long time, and the problem of technical "stuck neck" needs to be solved
.
With the continuous introduction of favorable policies, the innovation strength of local pharmaceutical machine enterprises is rising, and the wave of domestic substitution of imports is coming.
In this context, pharmaceutical machine enterprises mastering technological advantages will help increase the added value of products, thereby gaining greater competition.
advantage
.

　　Third, speed up the transformation of "roles"
.
The current pharmaceutical machine market is no longer an era when users could be moved by a single product in the past, but requires a combination of software and hardware to compete in the market with an overall solution
.
Therefore, in order to cope with the various changes in the innovative drug market, pharmaceutical machine companies need to adjust their role in a timely manner and transform to an overall solution
.

　　Original title: The domestic innovative drug R&D and listing situation is very good.
How does the pharmaceutical machinery industry do the "engine" work?

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.